Legume Consumption not significantly linked to improvement of CVD And Diabetes Risk In Healthy Adults

Written By :  Dr. Kamal Kant Kohli
Published On 2023-06-10 01:30 GMT   |   Update On 2023-06-10 05:30 GMT
Advertisement

Consuming legumes, such as beans, lentils, peas, and soybeans, may not have a significant impact on the risk of cardiovascular disease (CVD) and type 2 diabetes (T2D) in healthy adults with low legume consumption, according to a recent systematic review. The study published in Food & Nutrition Research aimed to evaluate the associations between legume consumption and CVD, T2D, and their risk factors in this population.

Advertisement

Researchers Birna Thorisdottir and team conducted a comprehensive search of several databases for randomized controlled trials (RCTs) and prospective cohort studies with follow-ups of at least 12 months. They analyzed the data from 31 cohort studies involving over 2 million participants and 14 crossover RCTs with 448 participants. The outcomes examined included CVD, coronary heart disease (CHD), stroke, T2D, and various blood lipids, glycemic markers, and blood pressure changes.

● Out of the 181 articles reviewed, 47 were selected for analysis in this study.

● These included 31 cohort studies involving a total of 2,081,432 participants with generally low legume consumption, 14 crossover randomized controlled trials (RCTs) with 448 participants, one parallel RCT, and one non-randomized trial.

● The meta-analyses of the cohort studies indicated no significant associations between legume consumption and cardiovascular disease (CVD), coronary heart disease (CHD), stroke, or type 2 diabetes (T2D).

● On the other hand, the meta-analyses of the RCTs suggested a potential protective effect of legume consumption on certain risk factors.

● These included reductions in total cholesterol (mean difference of -0.22 mmol/L), low-density lipoprotein (LDL)-cholesterol (-0.19 mmol/L), fasting glucose levels (-0.19 mmol/L), and homeostatic model assessment for insulin resistance (HOMA-IR) (-0.30).

● There was considerable heterogeneity among the RCT results, with an I2 value of 52% for LDL-cholesterol and over 75% for the other outcomes.

● Overall, the evidence regarding the associations between legume consumption and the risk of CVD and T2D was considered limited, and no definitive conclusion could be drawn from the available data.

In summary, while legume consumption may not directly affect the risk of CVD and T2D in healthy adults with low legume intake, the study suggests that including legumes as part of a varied and nutritious diet could contribute to improved risk factors associated with these conditions. Future studies are warranted to further explore the potential benefits of legume consumption in preventing CVD and T2D.

Reference:

Thorisdottir, B., Arnesen, E. K., Bärebring, L., Dierkes, J., Lamberg-Allardt, C., Ramel, A., Nwaru, B. I., Söderlund, F., & Åkesson, A. (2023). Legume consumption in adults and risk of cardiovascular disease and type 2 diabetes: a systematic review and meta-analysis. Food & Nutrition Research, 67. https://doi.org/10.29219/fnr.v67.9541

Tags:    
Article Source : Food & Nutrition Research

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News